1/100
Looks like no tags are added yet.
What is the pathophysiology of anemia of CKD?
kidneys secrete 90% of erythropoietin (EPO)
↓ EPO → inadequate production of oxygen-carrying RBCs
results in: decreased erythrocyte half-life, iron deficiency, blood loss
What is the risk of anemia of CKD?
↑ morbidity & mortality from CV complications
What are the consequences of anemia of CKD?
fatigue
depression
reduced exercise tolerance
dyspnea
CV consequences (left ventricular hypertrophy, left ventricular systolic dysfunction)
What are symptoms of anemia in CKD?
fatigue/weakness/dizziness
headache, sob
mental confusion
cold intolerance, cold hands & feet
tingling in extremities
chest pain
pale skin
irregular heart beat
What are the diagnostic criteria of anemia?
men: hemoglobin <13 g/dL
women: hemoglobin <12 g/dL
What are the screening protocols of anemia?
evaluate levels in all CKD patients
anemia prevalence increases at stage G3
CBC, absolute reticulocyte count, serum ferritin, serum transferrin saturation, B12, folate
What are reasons for iron deficiency?
increased requirement for RBC production with ESA therapy
blood loss from bleeding or hemodialysis
How is iron status evaluated?
TSAT assesses available iron (serum iron/TIBC*100)
ferritin measures stored iron
What ferritin & TSAT levels indicate iron deficiency anemia in pts receiving hemodialysis?
ferritin ≦500ng/ml
TSAT ≦30%
What ferritin & TSAT levels indicate iron deficiency anemia in pts not receiving hemodialysis?
ferritin <100ng/ml + TSAT <40% OR
ferritin <300ng/ml + TSAT <25%
What is the treatment for iron deficiency anemia?
either IV iron (HD) or 1-3 months or oral iron (non-HD)
What are the guideline treatment targets for iron therapy?
reasonable to withhold routine iron if:
ferritin >700ng/ml
TSAT ≧40%
What are the treatment goals of anemia in CKD?
increase oxygen-carrying capacity
improve QOL
decrease the need for blood transfusion
What is the dosing of oral iron?
200mg of elemental iron daily
What are the pros of oral iron?
inexpensive
readily available
doesn’t require IV access
What are the cons of oral iron?
GI side effects (dyspepsia, constipation)
compliance
What is the dosing of IV iron?
initial dose of 1000mg
When is IV dosing preferred to oral?
HD pts
pt does not respond to/tolerate oral
What are the pros of IV iron?
avoids concerns about adherence
What are the cons of IV iron?
requires IV access
severe infusion related reactions (rarely)
What is the recommendation for the initial admin of IV iron dextran?
monitor pt for 60mins after infusion
availability of resuscitative facilities included trained personnel
What is the recommendation for the initial admin of IV non-dextran iron?
suggested to monitor patients after infusion
availability of resuscitative facilities included trained personnel
What are nonspecific ADRs of IV iron therapy & what should be done if they occur?
chest tightness
dizziness
lightheadedness
nausea
itching
asymptomatic hypotension
STOP infusion
observe 15 mins
restart if well at 25%-50% rate
What are mild ADRs of IV iron therapy & what should be done if they occur?
nonspecific reaction PLUS minor urticaria
STOP infusion
observe
retrial after steroid or oral H1 blocker
restart if well at 25%-50% rate
What are moderate ADRs of IV iron therapy & what should be done if they occur?
severe chest pain
cough
tachycardia
hypotension
severe generalized urticaria
STOP infusion
give IV fluids
IV steroid 100mg hydrocortisone
H1 blocker
restart if well at 25%-50% rate
consider alt. iron preparation
What are severe ADRs of IV iron therapy & what should be done if they occur?
sudden onset of:
wheezing
stridor
cyanosis
hypotension
tachycardia
STOP infusion
give IV fluids
15L oxygen
0.5mg 1:1000 IM adrenaline
corticosteroid IV
β₂-adrenoreceptor agonist bronchodilator w/ nebulizer
AVOID future use
Which iron agent shows a slower increase in Hb, ferritin, or TSAT?
oral iron
What is the difference in ADRs of oral vs. IV iron?
oral: more frequent, less severe
IV: less frequent, more severe
Which iron agent is more expensive?
IV iron
Why may oral iron be more appealing than IV?
people who want to limit hospital visits
mobility inequality
preserves veins for HD vascular access
Which iron agent may show increased assured administration?
IV iron
Which iron agent should be avoided if intestinal absorption is impaired?
oral iron
What is the MOA of erythropoiesis-stimulating agents (ESA)?
glycoproteins manufactured by recombinant DNA tech
same biological activity as EPO → stimulates erythropoiesis
What must occur before ESA therapy is initiated?
correction of iron deficiency
Which agents are ESAs?
epoetin alfa (epogen, procrit)
epoetin-alfa-epbx (retacrit)
darbepoetin alfa (anaesp)
methoxy PEG-epoetin beta (mircera)
Which ESA agents are dosed three times weekly?
epoetin alfa
epoetin-alfa-epbx
Which ESA agent is dosed once weekly or every 2 weeks?
darbepoetin alfa
Which ESA agent is dosed every 2 weeks or monthly?
methoxy PEG-epoetin beta
At what Hgb levels may ESA be started in non-HD pts?
<10g/dL
At what Hgb levels should ESA be started in HD pts?
<10g/dL
What is initial dosing of epoetin alfa?
IV or SQ 50-100 units/kg/week divided into 3 weekly doses
What is initial dosing of darbepoetin?
IV or SQ 0.45 mcg/kg once weekly OR 0.75 mcg/kg every 2 weeks
What is the route of admin of ESA on HD or hemofiltration?
IV or SQ
What is the route of admin of ESA on peritoneal dialysis or not on hemodialysis?
SQ
When are ESA & IV iron generally used in combination?
stage 5 CKD on HD
When should ESA agents be evaluated for titration?
in 2-4 weeks
What should be done if Hgb changes by <1g/dL @ week 4?
dose should be increased 25%
What should be done if Hgb changes by >1g/dL @ week 2?
dose should be decreased 25%
What is the Hgb treatment target on ESAs?
<11.5g/dL
What are ESA ADRs?
hypertension
headache
flu-like
What are signs of ESA hypo-responsiveness?
iron deficiency
hyperparathyroidism
folate or vitamin B12 deficiency
malignancies
malnutrition
What should be monitored in anemia in CKD?
once stable, Hgb at least monthly
iron status at least every 3 months while on ESA therapy
What is the pathophysiology of mineral & bone disorders in CKD?
kidney function decline → ↓ phosphorus elimination → ↓ serum calcium concentration → ↑ PTH secretion
PTH ↓ phosphorous and ↑ calcium reabsorption in kidneys, mobilizing calcium from bone
also decreased conversion of dietary vitamin D → calcitriol, ↓ intestinal calcium absorption
What is the result of hyperphosphatemia?
↑ PTH → bone breakdown → renal osetodystrophy
↑CaPO4 product → precipitation in arteries, joints, soft tissues, & the viscera
Which level should be managed first (phosphorus/calcium/PTH)?
phosphorus
What is the target level of phosphorus?
2.5-4.5 mg/dL
What is the target level of calcium?
8.5-10.5 mg/dL
What is the target level of PTH?
2-9x ULN (120-540 pg/mL)
normal range 10-65 ng/L
What is the non-pharmacologic therapy for hyperphosphatemia in CKD?
dietary phosphorous restrictions in stage 3 or higher (800-1000mg/day)
dialysis removes various amounts of phosphorous (insufficient to maintain appropriate level)
What are the characteristics of phosphate binders?
not for prevention of hyperphosphatemia
reduces phosphorus absorption & serum levels
forms insoluble complexes that are excreted in stool
must be taken with meals
What foods are high in phosphorous?
seeds
chocolate
fish/shellfish
nuts
pork/beef/veal
low fat dairy
tofu
beans/lentils
cheese
beer/carbonated drinks
What agents are phosphate binders?
aluminum-containing
calcium-containing
sevelamer/lanthanum
Which phosphate binder agent should be avoided & why?
aluminum-containing phosphate binders
aluminum toxicity
What dose of elemental calcium should not be exceeded?
1500mg/day
to prevent tissue calcification
With what measures are calcium-containing phosphate binders not recommended?
calcium >10.2 mg/dL
PTH <150 pg/mL
What agent is suggested for lowering serum phosphorus levels?
calcium-based phosphate binders are effective in lowering serum phosphorus levels
in adults with CKD G3a-5 receiving phosphate-lowering treatment, calcium-based phosphate should be restricted
What is the impact of CKD on vitamin D?
the ability to convert 25D → 1,25D is lost as kidney function declines
What are the effects of active vitamin D administration for CKD patients?
suppresses PTH → stimulation of calcium & phosphorus absorption in intestines
improves bone histology, increases BMD
After what parameter is reached should vitamin D be given in CKD?
after PO4 levels are controlled
vitamin D can worsen hyperphosphatemia because it increases absorption in intestines
What agents are the inactive form (precursor) of vitamin D (PO)?
ergocalciferol (D2)
cholecalciferol (D3)
calcifediol (D3)
What agents are activated vitamin D (PO or IV)?
calcitriol
paricalcitol
doxercalciferol
When should vitamin D (D2 or D3) be administered in CKD?
stages 3-5
serum levels of 25(OH)-vitamin D are low (<30 ng/dL)
severe & progressive hyperparathyroidism
calcium <9.5 mg/dL + phosphorous <4.6 mg/dL
What are dosage adjustments of inactive vitamin D based on?
PTH, calcium, & phosphorous levels
When should active vitamin D be considered in CKD?
if PTH remains elevated despite adequate 25(OH)D levels
stage 5 CKD
What is the efficacy of IV vs PO calcitriol?
iv is more effective
iv also has a high incidence of hypercalcemia
What is the MOA of calcimimetics?
attaches to calcium receptor in parathyroid gland & increases sensitivity of receptors to serum calcium concentration, reducing PTH
What is the place in therapy of calcimimetics?
useful in patients with high calcium/phosphate/PTH
CKD stage 5
What agents are calcimimetics?
cinacalcet HCl (sensipar)
etelcalcetide
What are the ADE of cinacalcet HCl?
hypocalcemia
What are the ADE of etelcalcetide?
hypocalcemia
longer half life than cinacalcet, more GI side affects
d/c cinacalcet HCl for at least 7 days prior to initiating etelcalcetide
When should serum calcium be monitored in stage 3?
every 6-12mo
When should serum calcium be monitored in stage 4?
every 3-6mo
When should serum calcium be monitored in stage 5?
every 1-3mo
When should serum phosphorus be monitored in stage 3?
every 6-12mo
When should serum phosphorus be monitored in stage 4?
every 3-6mo
When should serum phosphorus be monitored in stage 5?
every 1-3mo
When should PTH be monitored in stage 3?
baseline & CKD progression
When should PTH be monitored in stage 4?
every 6-12mo
When should PTH be monitored in stage 5?
every 3-6mo
When should 25(OH)D be monitored in CKD?
baseline & following therapeutic intervention
What agent should be used if ↑phos and avoided if ↓phos?
binders
What agent should be used if ↑PTH (↓Ca) & avoided if ↓PTH, ↑Ca, ↑phos?
calcitriol
What agent should be used if ↑PTH, ↑Ca, ↑phos & avoided if ↓Ca, ↓phos?
cinacalcet
What is the pathophysiology of sodium & water abnormalities in CKD?
reduced ability to concentrate/dilute water
significant sodium retention can occur
volume overload with pulmonary edema
HTN
What is the goal of therapy in sodium & water retention in CKD?
maintain sodium concentration (135-145 mEq/L) & euvolemic state
restrict dietary sodium & fluid intake
What agents are used in sodium & water abnormalities in CKD?
stage 1-3 → thiazide
stage 4-5 → loop
What is the pathophysiology of potassium abnormality in CKD?
kidney’s excrete 90-95% of dietary potassium load
advanced CKD → hyperkalemia
What are the goals of therapy in potassium retention in CKD?
prevent hyperkalemia
dietary restriction, limit meds that can increase potassium
What are treatment options for hyperkalemia in CKD?
sodium potassium exchange resins
kayexalate-sps
veltassa-patiromer
lokelma-szc
hemodialysis
acute management
What is the pathophysiology of metabolic acidosis in CKD?
serum bicarbonate concentrations less than 22 mmol/l → associated with increased risk of CKD progression & mortality